Generic Drug Portfolio

About Shenzhen Salubris Pharmaceuticals

Shenzhen Salubris Pharmaceuticals Co., Ltd. is a leading Chinese pharmaceutical company that develops, manufactures, and commercializes pharmaceutical products and medical devices. The company has built a diversified portfolio spanning multiple therapeutic areas with a focus on high-quality generic drugs and innovative pharmaceutical solutions. Listed on the Shenzhen Stock Exchange, Salubris has established itself as a significant player in China's pharmaceutical market with strong manufacturing capabilities and expanding R&D operations.

About Towa Pharmaceutical

Towa Pharmaceutical is a major Japanese generic drug manufacturer with a mission to contribute to public health by supplying stable, high-quality, and affordable generic medicines. The company has established a strong market position in Japan through its extensive portfolio of generic products and its manufacturing capabilities. Its strategic direction includes expanding its product lineup, enhancing production efficiency, and exploring opportunities in biosimilars and other advanced generic segments. As a publicly traded entity, it operates with a focus on sustainable growth and shareholder returns.

Therapeutic Areas

Other Various Therapeutic Areas Drugs